Complementary and alternative medicine (CAM) use among Jordanian patients with chronic diseases

Complementary Therapies in Clinical Practice

Volumn 19, Issue 3, 2013, Pages 153-157

  Wazaify, Mayyada ^a   Alawwa, Izzat ^b   Yasein, Nada ^b   Al Saleh, Akram ^b   Afifi, Fatma U ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

^b JORDAN UNIVERSITY HOSPITAL   (Jordan)

Author keywords

Chronic kidney diseases; Diabetes mellitus; Dyslipidemia; Herbs; Hypertension; Jordan

Indexed keywords

PLANT MEDICINAL PRODUCT;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHRONIC DISEASE; CHRONIC KIDNEY DISEASES; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HERB; HIBISCUS; HUMAN; HYPERTENSION; JORDAN; MALE; MIDDLE AGED; PHYTOTHERAPY; SEX DIFFERENCE; UTILIZATION REVIEW;

CHRONIC KIDNEY DISEASES; DIABETES MELLITUS; DYSLIPIDEMIA; HERBS; HYPERTENSION; JORDAN;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHRONIC DISEASE; DYSLIPIDEMIAS; FEMALE; HIBISCUS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT PREPARATIONS; RENAL INSUFFICIENCY, CHRONIC; SEX FACTORS; YOUNG ADULT;

EID: 84880720323     PISSN: 17443881     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctcp.2013.03.001     Document Type: Article

References (32)

1. World Health Organization (WHO) Guidelines on developing consumer information on proper use of traditional, complementary and alternative medicine 2004, WHO Publications, Geneva.
2. Zaid H., Rayan A., Said O., Saad B. Cancer treatment by Greco-Arab and Islamic herbal medicine. Open Nutraceuticals J 2010, 3:203-221.
3. Afifi F., Abu Irmailah B. Herbal medicine in Jordan with special emphasis on less commonly used medicinal herbs. JEthnopharmacol 2000, 72:101-110.
4. Azaizeh H., Fulder S., Khalil O., Said O. Ethnobotanical knowledge of local Arab practitioners in the Middle Eastern region. Fitoterapia 2003, 74:98-108.
5. Kassabri V., Afifi F.U., Hamdan I. Invitro and invivo acute antihyperglycemic effects of selected five indigenous plants from Jordan used in traditional medicine. JEthnopharmacol 2011, 13:888-896.
6. Bei W.J., Guo J., Wu H.Y., Cao Y. Lipid-regulating effect of traditional Chinese medicine: mechanisms of actions. Evid Based Complement Alternat Med 2012, 1-10. Article ID970635.
7. Oran S.A., Al-Eisawi D.M. Check-list of medicinal plants in Jordan. Dirasat 1998, 25:84-111.
8. Wazaify M., Afifi F.U., El-Khateeb M., Ajlouni K. Complementary and alternative medicine use among Jordanian patients with diabetes. Complement Ther Clin Pract 2011, 17:71-75.
9. Franco O.H., Peeters A., Bonneux L., de Laet C. Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women. Hypertension 2005, 46:280-286.
10. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., He J. Global burden of hypertension: analysis of worldwide data. The Lancet 2005, 365:5217-5223.
11. Erem C., Hacihasanoglu A., Kocak M., Deger O., Topbas M. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon hypertension study. JPublic Health 2008, 31:47-58.
12. Saeed A.A., Al-Hamdan N.A., Bahnassy A.A., Abdalla A.M., Abbas M.A.F., Abuzaid L.Z. Prevalence, awareness, treatment, and control of hypertension among Saudi adult population: a national survey. Int J Hypertens 2011, 1-8. Article ID 174135.
13. Mubarak F.M., Erika S., Froelicher E.S., Jaddou H.Y., Ajlouni K.M. Hypertension among 1000 patients with type 2 diabetes attending a national diabetes center in Jordan. Ann Saudi Med 2008, 28:346-351.
14. Tee S.R., Teoh X.Y., Aiman W.A.R.W.M., Aiful A., Har C.S.Y., Tan Z.F., et al. The prevalence of hypertension and its associated risk factors in two rural communities in Penang, Malaysia. IeJSME 2010, 4:27-40.
15. Tesfaye F., Byass P., Wall S. Population based prevalence of high blood pressure among adults in Addis Ababa: uncovering a silent epidemic. BMC Cardiovasc Disord 2009, 9:39-49.
16. Ali-Shtayeh M.S., Jamous R.M., Al-Shafieh J.H., Elgharabah W.A., Kherfan F.A., Qarariah K.H., et al. Traditional knowledge of wild edible plants used in Palaestine (Northern West Bank): a comparative study. JEthnobiol Ethnomed 2008, 4:1-13.
17. Lev E., Amar Z. Ethnopharmacological survey of traditional drugs sold in Israel at the end of the 20th century. JEthnopharmacol 2000, 72:191-205.
18. Lev E., Amar Z. Ethnopharmacological survey of traditional drugs sold in the Kingdom of Jordan. JEthnopharmacol 2002, 82:131-145.
19. Said O., Khalil K., Fulder S., Azaizeh H. Ethnopharmacological survey of medicinal herbs in Israel, the Golan Heights and the West Bank region. JEthnopharmacol 2002, 83:251-265.
20. Afifi F.U., Wazaify M., Jabr M., Treish E. The use of herbal preparations as complementary and alternative medicine (CAM) in a sample of patients with cancer in Jordan. Complement Ther Clin Pract 2010, 16:208-212.
21. Albedah A.M., El-Olemy A.T., Khalil M.K. Knowledge and attitude of health professionals in the Riyadh region, Saudi Arabia, toward complementary and alternative medicine. JFam Community Med 2012, 19:93-99.
22. American Cancer Society; 2012. Available from: [last accessed Sep 20, 2012]. http://www.cancer.org/Treatment/TreatmentsandSideEffects/ComplementaryandAlternativeMedicine/HerbsVitaminsandMinerals/cupping.
23. Elolemy A.T., Albedah A.M. Public knowledge, attitude and practice of complementary and alternative medicine in Riyadh region, Saudi Arabia. Oman Med J 2012, 27:20-26.
24. Wojcikowski K., Johnson D., Gobe G. Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies. JLab Clin Med 2006, 147:160-166.
25. Wang Y., Heb L., Sun W., Lu Y., Wang X.Q., Zhang P.Q., et al. Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: a multicenter double-blinded randomized controlled trial. JEthnopharmacol 2012, 139:757-764.
26. Miller L.G. Herbal medicinals - selected clinical considerations focusing onknown or potential drug-herb interactions. Arch Intern Med 1998, 158:2200-2211.
27. Morike K., Gleiter C.H. Phytotherapeutic medicines. A possible source of drug interactions. Internist (Berlin) 2003, 44:748-752.
28. Wang J., Wang F., Yun H., Zhang H., Zhang Q. Effect and mechanism of fucoidan derivatives from Laminaria japonica in experimental adenine-induced chronic kidney disease. JEthnopharmacol 2012, 139:807-813.
29. Li X.M., Wang H.Y. Chinese herbal medicine in the treatment of chronic kidney disease. Adv Chronic Kidney Dis 2005, 12:276-281.
30. Lin C.C., Lin L.T., Yen M.H., Cheng J.T., Hsing C.H., Yeh C.H. Renal protective effect of Xiao-Chai-Hu-Tang on diabetic nephropathy of trype 1-Diabetic mice. Evid Based Complement Alternat Med 2012, 1-11. Article ID 984024.
31. Ren Y., Sun W., Zhao Y., Ma Q., Wang Z. Effect of Qufengtongluo recipe on expression of nephrin mRNA in adriamycin-induced nephropathy in rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2009, 34:1216-1223.
32. Zuo C., Xie X.S., Qiu H.Y., Deng Y., Zhu D., et al. Astragalus mongholicus ameliorates renal fibrosis by modulating HGF and TGF-beta in rats with unilateral ureteral obstruction. JZhejiang Univ Sci B 2009, 10:380-390.